Registro completo |
Provedor de dados: |
BJMBR
|
País: |
Brazil
|
Título: |
Cotransfected human chondrocytes: over-expression of IGF-I and SOX9 enhances the synthesis of cartilage matrix components collagen-II and glycosaminoglycans
|
Autores: |
Simental-Mendía,M.
Lara-Arias,J.
Álvarez-Lozano,E.
Said-Fernández,S.
Soto-Domínguez,A.
Padilla-Rivas,G. R.
Martínez-Rodríguez,H. G.
|
Data: |
2015-12-01
|
Ano: |
2015
|
Palavras-chave: |
Type II collagen
Glycosaminoglycans
IGF-I/SOX9 transgenes
Human chondrocytes
Articular cartilage
Cotransfection
|
Resumo: |
Damage to cartilage causes a loss of type II collagen (Col-II) and glycosaminoglycans (GAG). To restore the original cartilage architecture, cell factors that stimulate Col-II and GAG production are needed. Insulin-like growth factor I (IGF-I) and transcription factor SOX9 are essential for the synthesis of cartilage matrix, chondrocyte proliferation, and phenotype maintenance. We evaluated the combined effect of IGF-I and SOX9 transgene expression on Col-II and GAG production by cultured human articular chondrocytes. Transient transfection and cotransfection were performed using two mammalian expression plasmids (pCMV-SPORT6), one for each transgene. At day 9 post-transfection, the chondrocytes that were over-expressing IGF-I/SOX9 showed 2-fold increased mRNA expression of the Col-II gene, as well as a 57% increase in Col-II protein, whereas type I collagen expression (Col-I) was decreased by 59.3% compared with controls. The production of GAG by these cells increased significantly compared with the controls at day 9 (3.3- vs 1.8-times, an increase of almost 83%). Thus, IGF-I/SOX9 cotransfected chondrocytes may be useful for cell-based articular cartilage therapies.
|
Tipo: |
Info:eu-repo/semantics/article
|
Idioma: |
Inglês
|
Identificador: |
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2015001201063
|
Editor: |
Associação Brasileira de Divulgação Científica
|
Relação: |
10.1590/1414-431x20154732
|
Formato: |
text/html
|
Fonte: |
Brazilian Journal of Medical and Biological Research v.48 n.12 2015
|
Direitos: |
info:eu-repo/semantics/openAccess
|